Clinical Trial

Effect of Rhopressa on Intraocular Pressure (IOP) in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension Post-SLT

Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated June 10, 2026 (before its estimated July 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to collect data about how Rhopressa affects IOP in patients who have had an SLT procedure in both eyes.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-03-04; most recent amendment 2026-06-08.
Status change: Recruiting → Active, Not Recruiting 2026-06-08
Status change: Not Yet Recruiting → Recruiting 2025-06-27
Trial Details
NCT Number NCT06865144
Lead Sponsor East Coast Institute for Research
Collaborators: Alcon, a Novartis Company, Florida Eye Specialists
Conditions Primary Open Angle Glaucoma or Ocular Hypertension
Enrollment 70 participants
Start Date 2025-06-27
Primary Completion 2026-07-31 (estimated)
Study Completion 2026-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-10